Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARRY KEITH LANCE

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1316913577
CMS profile
59805
Location
LAUREL, MD

General Payments · PY2018–2024

$2,453.82

  • Reported across 134 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$312.58

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $312.58 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $168.54 8
Novo Nordisk AS $76.49 4
NOVARTIS PHARMACEUTICALS CORPORATION $24.87 1
Corcept Therapeutics $22.57 1
Tandem Diabetes Care, Inc. $20.11 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $404.22 24
PY2019 $215.46 14
PY2020 $213.65 12
PY2021 $364.02 20
PY2022 $434.34 21
PY2023 $509.55 28
PY2024 $312.58 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Corcept Therapeutics $22.57 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117756283 CMS
Lilly USA, LLC $31.89 01/24/2024 Food and Beverage Undisputed 01/23/2026 1136057126 CMS
Lilly USA, LLC $9.75 04/01/2024 Food and Beverage Undisputed 01/23/2026 1136062994 CMS
Lilly USA, LLC $11.35 04/25/2024 Food and Beverage Undisputed 01/23/2026 1136005729 CMS
Lilly USA, LLC $26.05 05/28/2024 Food and Beverage Undisputed 01/23/2026 1136057128 CMS
Lilly USA, LLC $13.17 07/02/2024 Food and Beverage Undisputed 01/23/2026 1136005727 CMS
Lilly USA, LLC $10.22 07/23/2024 Food and Beverage Undisputed 01/23/2026 1136061956 CMS
Lilly USA, LLC $31.22 08/27/2024 Food and Beverage Undisputed 01/23/2026 1136062078 CMS
Lilly USA, LLC $34.89 09/09/2024 Food and Beverage Undisputed 01/23/2026 1136005731 CMS
Novartis Pharmaceuticals Corporation $24.87 01/30/2024 Food and Beverage Undisputed 01/23/2026 1087053364 CMS
Novo Nordisk Inc $23.90 01/03/2024 Food and Beverage Undisputed 01/23/2026 1096904867 CMS
Novo Nordisk Inc $14.65 02/01/2024 Food and Beverage Undisputed 01/23/2026 1096887394 CMS
Novo Nordisk Inc $15.11 03/13/2024 Food and Beverage Undisputed 01/23/2026 1097201894 CMS
Novo Nordisk Inc $22.83 07/15/2024 Food and Beverage Undisputed 01/23/2026 1097820925 CMS
Tandem Diabetes Care, Inc. $20.11 03/12/2024 Food and Beverage Undisputed 01/23/2026 1138739939 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.